Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way
- PMID: 30693384
- DOI: 10.1007/s00467-019-4192-7
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
